These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 9641173)

  • 21. Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment.
    Zannetti BA; Zamagni E; Santostefano M; De Sanctis LB; Tacchetti P; Mancini E; Pantani L; Brioli A; Rizzo R; Mancuso K; Rocchi S; Pezzi A; Borsi E; Terragna C; Marzocchi G; Santoro A; Cavo M
    Am J Hematol; 2015 Jul; 90(7):647-52. PubMed ID: 25858483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined renal proximal tubulopathy and crystal storing histiocytosis in a patient with κ light chain multiple myeloma.
    Ungari M; Ghiringhelli P; Marchi G; Fisogni S; Lavazza A; Molteni A; Malberti F; Bertoni R; Trombatore M; Ferrero G; Gusolfino MD; Varotti E; Tanzi G; Manotti L
    Pathologica; 2021 Aug; 113(4):285-293. PubMed ID: 34463673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of Clinical Characteristics, Laboratory Parameters and Treatment Regimens on Prognosis of Patients with Multiple Myeloma].
    Xu L; Chen ZL; Hu M; Tao S; Chen Y; Su GH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1166-1172. PubMed ID: 31418374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged renal survival in light chain amyloidosis: speed and magnitude of light chain reduction is the crucial factor.
    Rezk T; Lachmann HJ; Fontana M; Sachchithanantham S; Mahmood S; Petrie A; Whelan CJ; Pinney JH; Foard D; Lane T; Youngstein T; Wechalekar AD; Bass P; Hawkins PN; Gillmore JD
    Kidney Int; 2017 Dec; 92(6):1476-1483. PubMed ID: 28729034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal impairment in multiple myeloma: A single center experience.
    Gorsane I; Barbouch S; Mayara M; Abdelghani KB; Goucha R; Hamida FB; Hedri H; Abdallah TB
    Saudi J Kidney Dis Transpl; 2016 May; 27(3):480-5. PubMed ID: 27215238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.
    Hutchison CA; Bradwell AR; Cook M; Basnayake K; Basu S; Harding S; Hattersley J; Evans ND; Chappel MJ; Sampson P; Foggensteiner L; Adu D; Cockwell P
    Clin J Am Soc Nephrol; 2009 Apr; 4(4):745-54. PubMed ID: 19339414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A clinical retrospective analysis of newly diagnosed multiple myeloma patients with systemic light chain amyloidosis].
    Liu Y; You HY; Yan LZ; Jin S; Shang JJ; Shi XL; Yan S; Yao WQ; Wu DP; Liu W; Fu CC
    Zhonghua Xue Ye Xue Za Zhi; 2022 Apr; 43(4):330-335. PubMed ID: 35680633
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and prognostic utility of cardiovascular magnetic resonance imaging in myeloma patients with suspected cardiac amyloidosis.
    Bhatti S; Watts E; Syed F; Vallurupalli S; Pandey T; Jambekar K; Mazur W; Hakeem A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):970-7. PubMed ID: 27225804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis.
    Innocenti S; Bacchi B; Allinovi M; Perfetto F; Antonioli E; Marchionni N; Di Mario C; Caroti L; Cappelli F; Stefàno P
    BMC Nephrol; 2022 Nov; 23(1):370. PubMed ID: 36397026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma].
    Rekhtina IG; Zakharova EV; Stolyarevich ES; Sinitsina MN; Denisova EN
    Ter Arkh; 2015; 87(6):98-101. PubMed ID: 26281203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous light chain amyloidosis with multiple myeloma: A concise review.
    Andrei M; Wang JC
    Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):71-81. PubMed ID: 30261180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Analysis of Cardiac Involvement in 53 Patients With Multiple Myeloma Coexistent With Light Chain Amyloidosis.
    Yu Y; Huang Z; Hu W; Li X; Shen M; Zhang J; Tang R; Chen S; Chen W
    Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):519-525.e1. PubMed ID: 32389672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Collaborative Study Defining Clinical Profile Outcomes and Novel Prognostic Criteria in Monoclonal Immunoglobulin M-Related Light Chain Amyloidosis.
    Sachchithanantham S; Roussel M; Palladini G; Klersy C; Mahmood S; Venner CP; Gibbs S; Gillmore J; Lachmann H; Hawkins PN; Jaccard A; Merlini G; Wechalekar AD
    J Clin Oncol; 2016 Jun; 34(17):2037-45. PubMed ID: 27114592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysproteinemia and the Kidney: Core Curriculum 2019.
    Hogan JJ; Alexander MP; Leung N
    Am J Kidney Dis; 2019 Dec; 74(6):822-836. PubMed ID: 31331759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Three cases of de novo multiple myeloma after kidney transplantation].
    Nieto-Ríos JF; Zuluaga M; Serna LM; Aristizábal A; Ocampo-Kohn C; Gálvez KM; Flórez AA; Zuluaga G
    Biomedica; 2016 Dec; 36(4):498-503. PubMed ID: 27992975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Amyloid Light-Chain Amyloidosis on Clinical Characteristics and Prognosis in Multiple Myeloma: A Single-Center Retrospective Study.
    Xu J; Wang M; Shen Y; Yan M; Xie W; Wang B; Liu H; Cen X
    Cancer Manag Res; 2021; 13():1343-1356. PubMed ID: 33603480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Renal failure in multiple myeloma and its treatment].
    Ryšavá R
    Vnitr Lek; 2020; 66(7):425-431. PubMed ID: 33380121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum free light chain level at diagnosis in myeloma cast nephropathy-a multicentre study.
    Yadav P; Sathick IJ; Leung N; Brown EE; Cook M; Sanders PW; Cockwell P
    Blood Cancer J; 2020 Mar; 10(3):28. PubMed ID: 32127527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary retinol binding protein predicts renal outcome in systemic immunoglobulin light-chain (AL) amyloidosis.
    Rezk T; Salota R; Gan JJ; Lachmann HJ; Fontana M; Siew K; Martinez-Naharro A; Guillotte C; Bass P; Sachchithanantham S; Mahmood S; Petrie A; Whelan CJ; Pinney JH; Dockrell M; Foard D; Lane T; Wechalekar AD; Hawkins PN; Walsh SB; Gillmore JD
    Br J Haematol; 2021 Sep; 194(6):1016-1023. PubMed ID: 34374069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.